Pharmaceuticals - General & Specialty - US: Developments to watch: 2018

CORPORATES SECTOR COMMENT 10 January 2018 Contacts Michael Levesque, CFA +1.212.553.4093 Senior Vice President Peter H. Abdill, CFA +1.212.553.4024 MD-Corporate Finance CLIENT SERVICES Americas 1-212-553-1653 Asia Pacific 852-3551-3077 Japan 81-3-5408-4100 EMEA 44-20-7772-5454 Pharmaceuticals - General & Specialty - US Developments to watch:
4 pages

Research Provider

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations

Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.

Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Read more

ResearchPool Subscriptions

Get the most out of your insights

Get in touch